Back
Nutex Health Vs. Crinetics Pharmaceuticals Industry Stock Comparison
Buy
63
NUTX
Nutex Health
Last Price:
$42.95
Seasonality Move:
24.18%
Sell
20
CRNX
Crinetics Pharmaceuticals
Last Price:
$38.81
Seasonality Move:
5.21%
Buy
63
Nutex Health (NUTX)
is a Buy
Is Nutex Health a Buy, Sell or Hold?
-
The current Nutex Health [NUTX] share price is $42.54. The Score for NUTX is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
-
NUTX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
20
Crinetics Pharmaceuticals (CRNX)
is a Sell
Is Crinetics Pharmaceuticals a Buy, Sell or Hold?
-
The current Crinetics Pharmaceuticals [CRNX] share price is $38.79. The Score for CRNX is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
-
CRNX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
NUTX Stock Price Chart
What is Nutex Health's stock price today?
-
The Nutex Health share price today is $42.54Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NUTX is experiencing slight buying pressure.
CRNX Stock Price Chart
What is Crinetics Pharmaceuticals's stock price today?
-
The Crinetics Pharmaceuticals share price today is $38.79Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRNX is experiencing slight selling pressure.
NUTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.01 | Buy |
Relative Strength Index (14 RSI): | 71.51 | Buy |
Chaikin Money Flow: | 5594 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (30.17 - 37.21) | Buy |
Bollinger Bands (100): | (21.78 - 34.66) | Buy |
CRNX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -4.39 | Sell |
Relative Strength Index (14 RSI): | 30.82 | Sell |
Chaikin Money Flow: | -261136 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (39.46 - 53.62) | Sell |
Bollinger Bands (100): | (47.18 - 58.74) | Sell |
NUTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 37.56 | Buy |
20-day SMA: | 34.48 | Buy |
50-day SMA: | 33.89 | Buy |
200-day SMA: | 18.27 | Buy |
8-day EMA: | 38.28 | Buy |
20-day EMA: | 35.66 | Buy |
50-day EMA: | 32.81 | Buy |
200-day EMA: | 28.11 | Buy |
CRNX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 37.7 | Buy |
20-day SMA: | 44.79 | Sell |
50-day SMA: | 51.74 | Sell |
200-day SMA: | 50.66 | Sell |
8-day EMA: | 39.37 | Sell |
20-day EMA: | 43.51 | Sell |
50-day EMA: | 48.92 | Sell |
200-day EMA: | 48.84 | Sell |
Nutex Health Earnings Growth & NUTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.74 per share, and an increase next year of $1.17 per share.
Crinetics Pharmaceuticals Earnings Growth & CRNX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.47 per share.
Nutex Health Technical Analysis
Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | Jan 21 | Jan 22 | Jan 23 | Jan 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
10 | 13 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Crinetics Pharmaceuticals Technical Analysis
Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | Jan 21 | Jan 22 | Jan 23 | Jan 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Jan | ||||||||||
10 | 13 | 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |